Literature DB >> 13515140

[Effect of antibacterial substances on bacterial toxins].

H STICKL, P WEGNER.   

Abstract

Keywords:  ANTIBIOTICS/effects; BACTERIA; SULFONAMIDES/effects

Mesh:

Substances:

Year:  1957        PMID: 13515140     DOI: 10.1007/bf01489035

Source DB:  PubMed          Journal:  Klin Wochenschr        ISSN: 0023-2173


× No keyword cloud information.
  11 in total

1.  [Adjuvants to antibiotic action. II].

Authors:  H STICKL
Journal:  Klin Wochenschr       Date:  1957-02-01

2.  [Modern liver therapy based on new experimental research].

Authors:  W EGER
Journal:  Dtsch Med Wochenschr       Date:  1956-04-13       Impact factor: 0.628

3.  [Treatment of hepatitis with antibiotics].

Authors:  E RISSEL; H SCHNACK
Journal:  Dtsch Med Wochenschr       Date:  1955-08-05       Impact factor: 0.628

4.  [Experimental studies on biological effect of Escherichia coli metabolic products].

Authors:  G BEYERHAUS; E LIENHOP; G STUTTGEN
Journal:  Arztl Forsch       Date:  1954-05-10

5.  [Connections between toxin neutralization and effects on immunization by chloromycetin in typhoid fevers].

Authors:  K O VORLAENDER; H SCHMITZ
Journal:  Arztl Wochensch       Date:  1952-10-03

6.  [Effect of aureomycin].

Authors:  K MULLI; K UHLENBROOCK; L LUDWIG
Journal:  Arzneimittelforschung       Date:  1953-11

7.  In vitro effect of aureomycin, terramycin, and chloramphenicol on typhus rickettsiae.

Authors:  A KARP; J C SNYDER
Journal:  Proc Soc Exp Biol Med       Date:  1952-02

8.  Effect of aureomycin on the respiration of normal rat liver homogenates.

Authors:  J C VAN METER; J J OLESON
Journal:  Science       Date:  1951-03-09       Impact factor: 47.728

9.  [Not Available].

Authors:  G RAMON; G GIRARD; R RICHOU
Journal:  C R Hebd Seances Acad Sci       Date:  1947-05-05

10.  Studies on the use of aureomycin in hepatic disease. II. The effect of aureomycin on experimental dietary hepatic necrosis.

Authors:  P GYORGY; J STOKES; W H SMITH; H GOLDBLATT
Journal:  Am J Med Sci       Date:  1950-07       Impact factor: 2.378

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.